Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care

Abstract

In primary care, 3.0% of children on chronic antiepileptic therapy are coprescribed therapeutic agents, which could give rise to clinically serious drug-drug interactions.